Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Screening topic
No spam. Unsubscribe anytime.
Committee discusses narrower amendment to newborn heart‑screening bill; sponsor to rework language
Summary
Lawmakers heard emotional testimony from families affected by undiagnosed congenital heart defects and discussed an amendment clarifying when providers should order further cardiac testing for newborns. The sponsor said the amendment was drafted after provider feedback and that the committee will roll the bill for technical revisions.
Get email alerts on the Health Screening topic
No spam. Unsubscribe anytime.
Members of the House Consumer & Public Affairs Committee heard testimony and adopted an amendment addressing House Bill 76, which concerns procedures to identify congenital heart disease (CHD) in newborns.
Sponsor Representative Thompson said the legislation aims to improve early detection of congenital heart defects by encouraging providers to collect family cardiac histories and to perform additional evaluation — such as pulse oximetry and echocardiography — when there are clinical indicators or family risk factors. The sponsor presented an amendment that narrows the set of risk indicators and clarifies that further testing should be performed during the newborn period when a provider determines it is needed based on a screening questionnaire developed by the Department of Health.
Several parents described long, traumatic experiences before a relative’s congenital heart condition was diagnosed, and asked lawmakers to make provider checklists and family‑history screening standard practice. Sandra Sanchez Farlander and Bob Farlander described founding a nonprofit after their son’s congenital atrial defect took 15 years to diagnose, saying better family‑history screening can lead to earlier intervention.
Committee members pressed for clarity about what the bill would mandate: whether any specific tests would be required for all newborns, what would trigger further testing, whether the measure creates any new follow‑up or quarantine protocol for recovered animals? (Note: the latter question refers to a separate item earlier in the hearing.) Sponsor Thompson said the bill does not mandate follow‑up medical care but asks providers to ask targeted family history questions and to use clinical judgment to order diagnostics such as echocardiograms or electrocardiograms when appropriate. The sponsor and members agreed the language needs further clarification; the committee voted to adopt the amendment and then agreed to roll the bill so sponsors can submit a substitute that clarifies the required family‑history collection and that further testing is discretionary and provider‑driven.
What’s next: The sponsor will prepare a substitute with clarified statutory placement and plain‑language guidance; committee members urged coordination with pediatric and rural providers to ensure practicable implementation.
